Related Experiment Video
Updated: Jun 9, 2025
03:22
Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
373
Overview of the Current Challenges in Pulmonary Coccidioidomycosis
Mohamed A Fayed1, Timothy M Evans1, Eyad Almasri1
1Pulmonary Critical Care Division, University of California San Francisco, Fresno Campus, Fresno, CA 93701, USA.
Journal of Fungi (Basel, Switzerland)
|October 25, 2024
Summary
Coccidioidomycosis, a fungal disease from inhaling spores, is increasing in the US. Diagnosis is challenging, often mimicking pneumonia, and requires further research for better clinical management.
Area of Science:
- Mycology
- Infectious Diseases
- Epidemiology
Background:
- Coccidioidomycosis is caused by Coccidioides fungi, with distinct species found in California and elsewhere.
- Transmission occurs via inhalation of fungal spores (arthroconidia), affecting mammals, including humans.
- The disease is endemic to the southwestern US, with increasing reported cases since 1995.
Purpose of the Study:
- To highlight the challenges in recognizing and diagnosing coccidioidomycosis.
- To emphasize the need for further research to improve clinical management.
- To inform clinicians about the complexities of this fungal infection.
Main Methods:
- This study is a review of coccidioidomycosis.
- Clinical presentation and diagnostic challenges are discussed.
- Epidemiological trends and geographical distribution are analyzed.
Main Results:
- Coccidioidomycosis presents a wide spectrum of illness, from asymptomatic to fatal.
- The infection often mimics bacterial pneumonia, complicating early recognition.
- Diagnosis relies heavily on serologic testing, which can have delayed results.
Conclusions:
- Coccidioidomycosis poses significant diagnostic and clinical challenges for healthcare providers.
- Suspected cases are frequently missed due to overlapping symptoms with other respiratory illnesses.
- Further research is essential to overcome hurdles in coccidioidomycosis presentation, diagnosis, and treatment.
Related Concept Videos
01:20COPD: Pathogenesis and Clinical Features
238
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
238
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
01:29Pulmonary Tuberculosis I
220
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
01:22Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
01:26COPD: Management Using Bronchodilators and Corticosteroids
182
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
182
01:28Pulmonary Tuberculosis II
212
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
212